Cat. No.: X25-04-YM1385
Polycaprolactone agent, Hyaluronate-PEG-PCL, Purity ≥95%
Synonym: Polycaprolactone-PEG-hyaluronate
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
| Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
|
X25-04-YM1385-1 |
PEG 350 Da |
Hyaluronate |
Polycaprolactone |
Inquiry
|
|
X25-04-YM1385-2 |
PEG 550 Da |
Hyaluronate |
Polycaprolactone |
Inquiry
|
|
X25-04-YM1385-3 |
PEG 750 Da |
Hyaluronate |
Polycaprolactone |
Inquiry
|
|
X25-04-YM1385-4 |
PEG 1 kDa |
Hyaluronate |
Polycaprolactone |
Inquiry
|
|
X25-04-YM1385-5 |
PEG 2 kDa |
Hyaluronate |
Polycaprolactone |
Inquiry
|
|
X25-04-YM1385-6 |
PEG 3 kDa |
Hyaluronate |
Polycaprolactone |
Inquiry
|
|
X25-04-YM1385-7 |
PEG 4 kDa |
Hyaluronate |
Polycaprolactone |
Inquiry
|
|
X25-04-YM1385-8 |
PEG 5 kDa |
Hyaluronate |
Polycaprolactone |
Inquiry
|
|
X25-04-YM1385-9 |
PEG 10 kDa |
Hyaluronate |
Polycaprolactone |
Inquiry
|
|
X25-04-YM1385-10 |
PEG 20 kDa |
Hyaluronate |
Polycaprolactone |
Inquiry
|
Properties
Description
The hyaluronate-PEG-PCL composite integrates polycaprolactone moieties through PEG-mediated linkage to hyaluronic acid chains, offering enhanced physicochemical properties suitable for experimental applications.
Glycan Structure
The glycan structure of hyaluronate (hyaluronic acid, HA) is a linear, non-sulfated glycosaminoglycan composed of repeating disaccharide units.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Applications
Hyaluronate-PEG-PCL plays a key role in facilitating controlled degradation kinetics in temporal drug delivery models.
Related Products
Quick Links